BioHealth News Archive
COVID-19 Research: Studying SARS CoV-2 Variants of Concern
Since its emergence in December 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide, causing a global pandemic (coronavirus disease-19 or…
Read MoreUniversity of Maryland | NSF Awards UMD $15M to Lead Mid-Atlantic…
The National Science Foundation (NSF) has selected the University of Maryland to lead one of five multi-institutional hubs that will provide entrepreneurial training to…
Read MoreBioHealth Innovation Adds Diane Ignar, Ph.D. and Dr. Loleta Robinson as NIH New Entrepreneurs-in-Residence · BioBuzz
ROCKVILLE, MARYLAND, August 23, 2021 – BioHealth Innovation Inc. (BHI) announces the addition of Diane Ignar, Ph.D., and Dr. Loleta Robinson to the expanding Entrepreneurs-in-Residence (EIR)…
Read MoreThe Secret’s Out: Mason is an economic driver | George Mason University
George Mason University boosts the Washington, D.C., metropolitan region economy by supplying an educated, skilled, and multifaceted workforce, by partnering with key employers, and…
Read MoreQIAGEN receives FDA authorization for rapid portable test
QIAGEN has announced it has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its QIAreach® SARS CoV-2 Antigen Test,…
Read MoreAURP 2021 – Innovation Elevated
Ranked among the top US states for thriving business climates for over six years, according to Forbes, Utah's tech prowess, unicorn startups and public-private development…
Read More9603 MEDICAL CENTER DRIVE Alexandria Center® for Life Science at Shady Grove
Alexandria Real Estate Equities, Inc. (NYSE:ARE), an S&P 500® company, is an office REIT uniquely focused on collaborative life science and technology campuses in…
Read MoreDiscover Frederick Maryland
In April of 2019, Kite, a Gilead Company, announced their decision to locate to Frederick County, MD and open a new manufacturing facility on…
Read MoreQiagen N.V. – QIAGEN reaches milestone with its kits used to process more than three billion biological samples to date
GERMANTOWN, Md. & HILDEN, Germany--(BUSINESS WIRE)-- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the number of biological samples processed with…
Read MoreCartesian Therapeutics Announces Clinical Responses in First Cohort of Phase 1b/2a Trial in Myasthenia Gravis | Cartesian
Gaithersburg, MD, August 24, 2021 – Cartesian Therapeutics, a fully integrated, clinical-stage biopharmaceutical company pioneering RNA cell therapy in and beyond oncology, today announced…
Read MoreGain Therapeutics – Protein Misfolding
Since the precise 3D structure of a protein is essential for its function, misfolding can result in significant downstream consequences. If this misfolding occurs…
Read MoreNovavax taps new execs in windup to Covid-19 vaccine launch – Washington Business Journal
The appointments are just the latest in a series of additions the company has made throughout the pandemic. Image: Stanley Erck is president and…
Read MoreGlycoMimetics CEO Rachel King steps down, successor named – Washington Business Journal
The exec has been at the helm of the company for 18 years. {iframe}https://www.bizjournals.com/washington/news/2021/08/05/glycomimetics-ceo-rachel-king-steps-down.html{/iframe}
Read MoreGain Therapeutics: A True Revolution In Drug Development (NASDAQ:GANX) | Seeking Alpha
With so many new public biotechnology companies minted in the last 18 months, it has become more difficult to sift out the winners from…
Read MoreBioHealth Innovation Adds Diane Ignar, Ph.D. and Dr. Loleta Robinson as NIH New Entrepreneurs-in-Residence
Biohealth and Entrepreneur Experts Joins Robust Entrepreneurs-in-Residence (EIR) Team ROCKVILLE, MARYLAND, August 23, 2021 – BioHealth Innovation Inc. (BHI) announces the addition of Diane Ignar, Ph.D.,…
Read More